CiToxLAB

Evreux, France Founded: 1969 • Age: 57 yrs Acquired By Charles River Laboratories
In vivo and in vitro toxicology services are provided globally.

About CiToxLAB

CiToxLAB is a Healthcare company based in Evreux (France) founded in 1969, and was acquired by Charles River Laboratories in February 2019. In vivo and in vitro toxicology services are provided globally. CiToxLAB has completed 3 acquisitions, including AccelLAB, Solvo Biotechnology and Xenometrics. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified.

Company details

CiToxLAB is a global CRO specializing in providing in vivo and in vitro toxicology services. CiToxLAB was formed by the merger of CiT Health and Safety Research Laboratories and LAB Research Inc. The company provides comprehensive services in toxicology and safety pharmacology, ADME, environmental risk assessment, clinical and non-clinical bioanalysis, clinical pathology, immunology and genomics, and other laboratory services. The company claims expertise in Infusion, Inhalation, Ocular routes to toxicology testing, as well as dermal studies and surgical implantation of medical devices.

Key Metrics

Investors in CiToxLAB

CiToxLAB has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Charles River Laboratories.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Provider of drug discovery and preclinical development services
1947criver.comWilmington, United States
Premium access

Investor details for CiToxLAB

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CiToxLAB

CiToxLAB has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include AccelLAB, Solvo Biotechnology and Xenometrics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Develops transporter assays
solvobiotech.comBudaors, Hungary1999Mar 2018β€’β€’β€’β€’
Non-clinical laboratory services in pharmacology and toxicology are offered.
xenometricsllc.comStilwell, United States2006Oct 2017β€’β€’β€’β€’
Preclinical research services for medical devices are offered.
accellab.comBoisbriand, Canada2004Nov 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for CiToxLAB

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of CiToxLAB

5 dated milestones of CiToxLAB across 50 years, from founding to its latest funding, stage changes and deals.

  1. Founded CiToxLAB is founded.
  2. Acquisition Acquires AccelLAB.
  3. Acquisition Acquires Xenometrics.
  4. Acquisition Acquires Solvo Biotechnology.
  5. Exit Acquired by Charles River Laboratories.

Web traffic of CiToxLAB

Websites that share an audience with CiToxLAB (citoxlab.com).

Similar websites

Websites whose visitors overlap most with CiToxLAB. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bioreliance.com
100%
2.1K#7,984,772View details
qps.com
99%
19.2K#1,101,936View details
midwestbioresearch.com
midwestbioresearch.com
98%
–
abtox.org
abtox.org
98%
#3,123,946–
majer.com.pl
majer.com.pl
69%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 11 similar websites and full traffic analytics for CiToxLAB

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Citoxlab

Premium access

Complete news archive for CiToxLAB

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CiToxLAB

CiToxLAB was founded in 1969.

CiToxLAB is headquartered in Evreux, France.

CiToxLAB is a global CRO specializing in providing in vivo and in vitro toxicology services. CiToxLAB was formed by the merger of CiT Health and Safety Research Laboratories and LAB Research Inc. The company provides comprehensive services in toxicology and safety pharmacology, ADME, environmental risk assessment, clinical and non-clinical bioanalysis, clinical pathology, immunology and genomics, and other laboratory services. The company claims expertise in Infusion, Inhalation, Ocular routes to toxicology testing, as well as dermal studies and surgical implantation of medical devices.

CiToxLAB has made 3 acquisitions, including AccelLAB, Solvo Biotechnology, and Xenometrics.

CiToxLAB has 1 investor. Key investors include Charles River Laboratories.

Yes. CiToxLAB was acquired by Charles River Laboratories in February 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available